title: Pro-MMP-9 is associated with poor prognosis in gastric cancer.
authors: Department of Physiological Chemistry and Metabolism, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
authors: Yukihiro
authors: Y
authors: Nomura
authors: Kunika
authors: K
authors: Takasaki
authors: Masakazu
authors: M
authors: Tada
authors: Masataka
authors: M
authors: Yoshimoto
authors: Hideyuki
authors: H
authors: Ishida
authors: Nobuo
authors: N
authors: Murata
authors: Shunichiro
authors: S
authors: Kubota
mesh_terms: D000230:Adenocarcinoma / Q000201:enzymology* / Q000401:mortality / Q000473:pathology; D000328:Adult; D000368:Aged; D004792:Enzyme Precursors / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000097:blood*; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000097:blood*; D011379:Prognosis; D013274:Stomach Neoplasms / Q000201:enzymology* / Q000401:mortality / Q000473:pathology
chemical_list: D004792:Enzyme Precursors; D009363:Neoplasm Proteins; C120487:pro-matrix metalloproteinase 9; D020780:Matrix Metalloproteinase 9